DXB 5.62% 42.0¢ dimerix limited

Ann: Dimerix Investor Call and Presentation, page-108

  1. 1,993 Posts.
    lightbulb Created with Sketch. 443
    Given it's not an Inhouse trial, we can only look at the progress so far in terms of timelines... and make a calculated guess!!

    Saying that even the first patient on FSGS still not recruited so no surprises there in terms of delay!!

    all the waiting time will be forgiven and forgotten if results are positive.... if not, I will just take DImerix off from watchlist and wait for another two years.... lol!!
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.